Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00872196 | A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies | PHASE2 | COMPLETED | 5 | — | — | Apr 1, 2009 | Apr 1, 2010 | Apr 1, 2013 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 - Follow-up Study | OTHER | This is a follow-up study with no treatment and only samples being collected. |
| Name | Type | Description |
|---|---|---|
| ABT-072 | DRUG | Blood samples are being taken from subjects previously treated with ABT-072. |
Inclusion Criteria: \- Main Selection Criteria: A subject that has received either ABT-072 or placebo in a prior study involving ABT-072. Exclusion Criteria: \- The investigator considers the subject unsuitable for the study for any reasons inclusive of, but not limited to, failure to comply with...